1 Min Read
Aug 28 (Reuters) - SetPoint
* secures $30 million series d equity financing
* Setpoint - series d equity funding supports clinical momentum; enables upcoming phase 2 trial in rheumatoid arthritis Source text for Eikon:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.